Patents by Inventor Thomas H. Ferguson

Thomas H. Ferguson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-methyl-thieno-benzodiazepine formulation
    Patent number: 7303764
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: December 4, 2007
    Assignee: Eli Lilly and Company
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Publication number: 20040097489
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Application
    Filed: July 3, 2003
    Publication date: May 20, 2004
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Patent number: 6617321
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation or olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Grant
    Filed: May 1, 2002
    Date of Patent: September 9, 2003
    Assignee: Eli Lilly and Company
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • 2-methyl-thieno-benzodiazepine formulation
    Publication number: 20030027816
    Abstract: The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
    Type: Application
    Filed: May 1, 2002
    Publication date: February 6, 2003
    Inventors: Douglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
  • Injectable sustained release formulation
    Patent number: 4977140
    Abstract: A dairy cow injected with a sustained release formulation comprising bovine somatotropin, a wax, and an oil produces more milk for 28 days.
    Type: Grant
    Filed: March 23, 1989
    Date of Patent: December 11, 1990
    Assignee: Eli Lilly and Company
    Inventors: Thomas H. Ferguson, Roger G. Harrison, David L. Moore
  • Method of making antimicrobial coated implants
    Patent number: 4952419
    Abstract: Uniform adherent coatings of antimicrobial agents are applied to the surface of implants by applying a film of silicone oil to the surface of the implant and then contacting the film-bearing surface with antimicrobial agents in a film-adherent powder form. A durable antimicrobial coating is formed. The coated implants can be packaged using mechanized implant handling equipment without significant loss of the antimicrobial coating.
    Type: Grant
    Filed: March 12, 1989
    Date of Patent: August 28, 1990
    Assignee: Eli Lilly and Company
    Inventors: Jose De Leon, Thomas H. Ferguson, Daniel S. Skinner, Jr.
  • Antimicrobial coated implants
    Patent number: 4846844
    Abstract: Uniform adherent coatings of antimicrobial agents are applied to the surface of implants by applying a film of silicone oil to the surface of the implant and contacting the film-bearing surface with antimicrobial agents in a film-adherent form. A durable antimicrobial coating is formed. The coated implants can be packaged using mechanized implant handling equipment without significant loss of the antimicrobial coating. In a preferred embodiment a controlled-release implant for administering an anabolic agent is coated with a durable nonvulcanizing silicone fluid plus oxytetracycline hydrochloride coating which does not interfere with diffusion of the anabolic agent from the implant.
    Type: Grant
    Filed: August 31, 1987
    Date of Patent: July 11, 1989
    Assignee: Eli Lilly and Company
    Inventors: Jose De Leon, Thomas H. Ferguson, Daniel S. Skinner, Jr.